1. Home
  2. Live Updates
  3. Johna scarlett

Live Breaking News & Updates on Johna scarlett

Stay informed with the latest breaking news from Johna scarlett on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Johna scarlett and stay connected to the pulse of your community

Geron to Participate at Upcoming Investor Conferences in April

Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the...

United-states , Johna-scarlett , Geron-corporation-nasdaq , Linkedin , Drug-administration , European-union , Geron-corporation , Chief-executive-officer , Annual-needham-virtual-healthcare-conference , Fireside-chat , Targeted-oncology-days

Geron to Participate at Upcoming Investor Conferences in April

Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron's Chairman and Chief Executive Officer, is scheduled to present at the following virtual investor conferences:



23rd Annual...

United-states , Johna-scarlett , European-union , Drug-administration , Linkedin , Geron-corporation-nasdaq , Upcoming-investor-conferences , Chief-executive-officer , Annual-needham-virtual-healthcare-conference , Fireside-chat , Targeted-oncology-days

Geron : Fiscal Year 2023 Annual Report -March 28, 2024 at 06:52 am EDT

2023


Annual Report


Letter to Stockholders


2024 Proxy Statement


2023 Annual Report on Form 10-K
...

California , United-states , Foster-city , Delaware , Scotta-samuels , Johna-scarlett , European-medicines-agency , Computershare-trust-company , European-commission , Ratification-of-ernst-young , Exchange-commission

Geron : Fiscal Year 2024 Proxy -March 28, 2024 at 06:52 am EDT

TABLE OF CONTENTS


UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


...

California , United-states , Foster-city , Washington , Delaware , Scotta-samuels , Johna-scarlett , Exchange-commission , Ratification-of-ernst-young , Fidelity-management-trust-company , Audit-committee

Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

June 16, 2024 PDUFA date for imetelstat NDA for the treatment of transfusion-dependent anemia in adult patients with lower-risk MDS

...

United-states , America , American , Gaurav-aggarwal , Johna-scarlett , Geron-corporation-nasdaq , European-union , Drug-administration , European-medicines-agency , Safety-evaluation-team , Linkedin , American-society-of-hematology-annual-meeting

Geron to Participate in the B. Riley Securities Virtual Oncology Conference

Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to participate in a...

United-states , Johna-scarlett , Linkedin , Drug-administration , Geron-corporation-nasdaq , Geron-corporation , Chief-executive-officer , Securities-virtual-oncology-conference , Nobel-prize-winning , New-drug-application , United-states-food

Geron to Participate at Upcoming Investor Conferences in November

Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the...

United-states , Piper-sandler , Johna-scarlett , Geron-corporation-nasdaq , Linkedin , Drug-administration , European-union , Geron-corporation , Chief-executive-officer , Fireside-chat , Annual-healthcare-conference , Corporate-presentation

Geron to Participate at Upcoming Investor Conferences in November

Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron's Chairman and Chief Executive Officer, is scheduled to present at the following investor conferences:



Stifel 2023 Healthcare...

United-states , Johna-scarlett , Piper-sandler , Geron-corporation-nasdaq , Drug-administration , Linkedin , European-union , Upcoming-investor-conferences , Chief-executive-officer , Fireside-chat , Annual-healthcare-conference , Corporate-presentation

Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results

Imetelstat is currently under regulatory review by the FDA and EMA for the treatment of transfusion-dependent anemia in adult patients with lower risk MDS


Planning is ongoing for a potential...

United-states , America , American , Johna-scarlett , Geron-corporation-nasdaq , Society-of-hematologic-oncology-annual-meeting , Momenta-pharmaceuticals-inc , Drug-administration , Safety-evaluation-team , European-union , Linkedin

EMA Validates MAA for Imetelstat for Transfusion-Dependent Anemia in Lower-Risk MDS

The European Medicines Agency has validated the marketing authorization application for the use of imetelstat in the treatment of transfusion-dependent anemia in patients with lower-risk myelodysplastic syndrome.

Geron-corporation , European-medicines-agency , Imetelstat , Transfusion-dependent-anemia-in-patients-with-lower-risk-myelodysplastic-syndrome , Imerge-trial , Nct02598661 , Johna-scarlett , D ,